ViewRay, Inc. (VRAY) Misses Q1 EPS by 5c

ViewRay, Inc. (Nasdaq: VRAY) reported Q1 EPS of ($0.35), $0.05 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $5.5 million versus the consensus estimate of $5.5 million.

"Momentum in our business continues to grow with the announcement that we plan to file for regulatory approval of our exciting new MRIdian linac technology in the second half of the year," said Chris A. Raanes, President and Chief Executive Officer of ViewRay. "We signed two new orders increasing our backlog to $89.6 million representing 16 signed sales contracts, installed a MRIdian system at VUmc in Amsterdam and expanded our pipeline of potential new customers interested in our linac technology."

For earnings history and earnings-related data on ViewRay, Inc. (VRAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c